Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study

BACKGROUND: Guidelines for general hypertension treatment do not recommend the combined use of renin-angiotensin-aldosterone system (RAAS) inhibitors due to the risk of hyperkalemia. However, a recent clinical trial showed that polycystic kidney disease (PKD) patients had infrequent episodes of hype...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoungnae, Park, Seohyun, Jhee, Jong Hyun, Yun, Hae-Ryong, Park, Jung Tak, Han, Seung Hyeok, Lee, Joongyub, Kim, Soo Wan, Kim, Yeong Hoon, Oh, Yun Kyu, Kang, Shin-Wook, Choi, Kyu Hun, Yoo, Tae-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434770/
https://www.ncbi.nlm.nih.gov/pubmed/30909873
http://dx.doi.org/10.1186/s12882-019-1292-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434770/
https://www.ncbi.nlm.nih.gov/pubmed/30909873
http://dx.doi.org/10.1186/s12882-019-1292-3

Ejemplares similares